NEW YORK--(BUSINESS WIRE)--MMIS, the company behind MediSpend® Global Compliance Platform, the leading global compliance and transparency solution for the life sciences industry, will be a sponsor at the 13th Annual Pharmaceutical Compliance Congress in Washington, DC on April 26-27, 2016.
Recognized by CIOReview for the second time as a leading pharma and life sciences technology solution provider, MediSpend has become the industry standard compliance solution, and the system of record for compliance management, monitoring, and reporting, for some of the world's largest life science companies.
“MMIS continues to outperform its competitors in the compliance life science market and is core to the compliance management, monitoring, and analysis work flow for life science companies,” said Michaeline Daboul, President and CEO, MMIS. “We look forward to attending PCC to discuss the challenges in meeting global transparency laws and regulatory demands, and to share how MediSpend is changing the way life science companies do business.”
MMIS will be showcasing its MediSpend Global Compliance Platform and working with customers and partners, including GoodData, to promote best practices that allow organizations to cost-effectively comply with transparency laws, analyze data, and securely communicate with healthcare providers across the world.
“Managing data to mitigate risk by monitoring business activities is an ongoing challenge faced by pharmaceutical companies,” stated GoodData Founder and CEO Roman Stanek. “By using GoodData’s cloud-based business analytics distribution platform MediSpend has brought self service dashboards to the life sciences market.”
In addition to exhibiting at PCC, executives from MMIS are leading the following tracks and activities:
Monday, April 25, 2:00 PM ET
Compliance Analytics Workshop
Preceding the PPC meeting, MMIS will host a hands-on Compliance Analytics Workshop for finance, legal, compliance and business leaders. Participants from leading pharmaceutical companies will use the Open Payments data and real-life compliance models to explore how they can benefit form cutting-edge business intelligence and analytics tools to monitor business behavior and mitigate risk.
Tuesday, April 26, 3:30 PM ET
Global Transparency of HCP Spend
Michaeline Daboul, MMIS President and CEO
Wednesday, April 27, 3:30 PM ET
Life Pre, During and Post-CIA-Impact on Internal Controls and Policies
Tim Robinson, MMIS Esq., Chief Knowledge Officer General Counsel
For more information about the 13th annual Pharmaceutical Compliance Congress, please visit PCC 2016. For more information and to request a demo of the MediSpend Global Compliance Platform, please visit www.medispend.com.
MMIS is a global technology company providing innovative compliance and business intelligence solutions for the life science industry. MMIS is a leading provider of cloud-based SaaS solutions dedicated to helping pharmaceutical, medical device and bio-pharmaceutical companies comply with state, federal and global laws.